Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
The clinical profile of cerebral small vessel disease: Toward an evidence-based identification of cognitive markersEmilia Salvadori, Michela Brambilla, Giorgia Maestri, et al.
Alzheimer Disease and Associated Disorders|February 10, 2016
Misidentification Delusions: Prevalence in Different Types of Dementia and Validation of a Structured QuestionnaireGiulia Perini, Alessandro Carlini, Simone Pomati, et al.
Cerebral Circulation - Cognition and Behavior|November 3, 2022
Comparison of Oxford Cognitive Screen and Montreal Cognitive Assessment feasibility in the stroke unit setting. A pilot studyMichela Brambilla, Martina Cerasetti, Fulvio Pepe, et al.
American Journal of Alzheimer'S Disease and Other Dementias|August 26, 2017
Self-Awareness for Memory Impairment in Amnestic Mild Cognitive Impairment: A Longitudinal StudyIlaria Cova, Giulia Grande, Valentina Cucumo, et al.
European Journal of Neurology|May 9, 2023
Early predictors of dysphagia in ischaemic stroke patientsDaniele Mattavelli, Francesco Mele, Ilaria Cova, et al.
Plos One|February 11, 2017
Nutritional status and body composition by bioelectrical impedance vector analysis: A cross sectional study in mild cognitive impairment and Alzheimer's diseaseIlaria Cova, Simone Pomati, Laura Maggiore, et al.
Frontiers in Aging Neuroscience|December 19, 2017
The Mirror Neurons Network in Aging, Mild Cognitive Impairment, and Alzheimer Disease: A functional MRI StudyElisabetta Farina, Francesca Baglio, Simone Pomati, et al.
Drugs & Aging|May 30, 2009
Memantine in moderately-severe-to-severe Alzheimer's disease: a postmarketing surveillance studyFrancesca Clerici, Nicola Vanacore, Antonietta Elia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 18, 2011
Memantine effects on behaviour in moderately severe to severe Alzheimer's disease: a post-marketing surveillance studyFrancesca Clerici, Nicola Vanacore, Antonietta Elia, et al.
Expert Opinion on Drug Safety|February 18, 2020
Treatment-related transient splenial lesion of the Corpus Callosum in patients with neuropsychiatric disorders: a literature overview with a case reportGiovanna Cirnigliaro, Ilaria Di Bernardo, Valentina Caricasole, et al.
Pageof 6